ADDENDUM NCCAM EXPLORATORY/DEVELOPMENTAL GRANT FOR CLINICAL STUDIES (R21) PAR-03-153 RELEASE DATE: February 5, 2004 NOTICE: NOT-CA-04-006 National Cancer Institute (NCI) ( This addendum is to inform potential applicants that the National Cancer Institute is co-sponsoring this announcement PAR-03-153 ( and is interested in research applications that focus on complementary and alternative medical approaches related to the prevention, diagnosis, and treatment of cancer as well as to the management of cancer symptoms and side effects due to conventional cancer treatment. Applicants are encouraged to review the most recent NCI Plan and Budget Proposal for additional information about topics that are of program relevance to the NCI. These documents are available at, by email at, or by telephone at 1-800-4-CANCER and are published each year. The document for fiscal 2004: The Nation’s Investment in Cancer Research: A Plan and Budget Proposal for Fiscal Year 2004 is NIH Publication No. 03-4373. Applicants are also encouraged to review the topics that have been processed through the NCI’s Best Case Series program. For additional information, see or contact Dr. Wendy Smith (see below). INQUIRIES Inquiries regarding this notice may be directed to: Wendy B. Smith, Ph.D. Program Director, Research Development and Support Program Office of Cancer Complementary and Alternative Medicine National Cancer Institute 6130 Executive Blvd, EPN Suite 102, MSC 7302 Bethesda, Maryland 20892-7302 Rockville, MD 20852 (for express/courier service) Telephone: 301-435-7980 FAX: 301-480-0075 Email:

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy
NIH... Turning Discovery Into Health®

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.